TDNA ETF
T. Rowe Price Biotech ETF
ARGX:AS is TDNA's largest holding at 5.03% of the fund as of Oct 15, 2026. TDNA is T. Rowe Price Biotech ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)Health Care · Biotechnology | 5.03% | 5.0% | 567 | $464.0K | Health Care | Biotechnology |
| 2 | K | Kymera Therapeutics IncHealth Care · Biotechnology | 4.20% | 9.2% | 3,629 | $387.7K | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | N | Natera Inc | 2.51% | 11.7% | 586 | $231.3K | ||
| 4 | K | Kodiak Sciences Inc | 2.49% | 14.2% | 2,836 | $230.0K | ||
| 5 | P | Vaxcyte Inc | 2.46% | 16.7% | 3,359 | $226.9K | ||
| 6 | R | Revolution Medicines Inc | 2.44% | 19.1% | 1,161 | $224.7K | ||
| 7 | M | Moderna Inc | 2.43% | 21.6% | 992 | $224.5K | ||
| 8 | I | Insmed Inc | 2.42% | 24.0% | 2,281 | $223.1K | ||
| 9 | U | United Therapeutics Corp | 2.38% | 26.4% | 407 | $219.8K | ||
| 10 | V | Vertex Pharmaceuticals Inc | 2.34% | 28.7% | 433 | $215.8K | ||
| 11 | A | Alnylam Pharmaceuticals Inc. | 1.96% | 30.7% | 804 | $180.5K | ||
| 12 | B | BridgeBio Pharma Inc | 1.94% | 32.6% | 2,760 | $179.2K | ||
| 13 | C | Cytokinetics Inc | 1.92% | 34.5% | 2,789 | $176.9K | ||
| 14 | R | Rhythm Pharmaceuticals Inc | 1.80% | 36.3% | 1,911 | $165.7K | ||
| 15 | D | Dianthus Therapeutics Inc | 1.77% | 38.1% | 2,182 | $163.1K | ||
| 16 | S | Spyre Therapeutics Inc | 1.72% | 39.8% | 2,015 | $158.4K | ||
| 17 | P | Praxis Precision Medicines Inc | 1.71% | 41.5% | 659 | $157.5K | ||
| 18 | M | Mirum Pharmaceuticals, Inc. | 1.67% | 43.2% | 1,930 | $154.3K | ||
| 19 | T | Tango Therapeutics Inc | 1.67% | 44.9% | 6,948 | $154.2K | ||
| 20 | M | Madrigal Pharmaceuticals Inc | 1.66% | 46.5% | 333 | $153.2K | ||
| 21 | C | CG Oncology Inc | 1.64% | 48.2% | 2,449 | $151.4K | ||
| 22 | A | Arrowhead Pharmaceuticals Inc | 1.63% | 49.8% | 2,571 | $150.1K | ||
| 23 | — | Alkermes PLC | 1.62% | 51.4% | 3,822 | $149.4K | ||
| 24 | E | Erasca Inc | 1.59% | 53.0% | 9,949 | $146.3K | ||
| 25 | T | Travere Therapeutics Inc | 1.58% | 54.6% | 2,737 | $145.8K | ||
| 26 | R | Relay Therapeutics Inc | 1.52% | 56.1% | 8,200 | $139.9K | ||
| 27 | S | Scholar Rock Holding Corp | 1.46% | 57.6% | 3,406 | $134.9K | ||
| 28 | T | Twist Bioscience Corp | 1.43% | 59.0% | 891 | $132.0K | ||
| 29 | — | Adarx Pharmaceuticals Inc | 1.30% | 60.3% | - | $119.9K | ||
| 30 | D | Dyne Therapeutics Inc | 1.26% | 61.6% | 7,703 | $115.9K | ||
| 31 | G | GRAIL Inc | 1.25% | 62.8% | 824 | $115.1K | ||
| 32 | B | Biogen Inc | 1.16% | 64.0% | 459 | $106.9K | ||
| 33 | K | Krystal Biotech Inc | 1.13% | 65.1% | 316 | $104.5K | ||
| 34 | B | Beam Therapeutics Inc. | 1.12% | 66.2% | 4,358 | $103.1K | ||
| 35 | N | Nurix Therapeutics Inc | 1.10% | 67.3% | 4,269 | $101.0K | ||
| 36 | D | Denali Therapeutics Inc | 1.05% | 68.4% | 5,401 | $96.5K | ||
| 37 | C | Celldex Therapeutics Inc | 1.04% | 69.4% | 3,448 | $96.0K | ||
| 38 | P | Protagonist Therapeutics Inc | 1.01% | 70.4% | 683 | $93.1K | ||
| 39 | I | IDEAYA Biosciences Inc | 0.99% | 71.4% | 2,705 | $91.6K | ||
| 40 | A | Amgen Inc. | 0.99% | 72.4% | 214 | $91.2K | ||
| 41 | H | Halozyme Therapeutics Inc | 0.98% | 73.4% | 772 | $90.2K | ||
| 42 | V | Viridian Therapeutics Inc | 0.98% | 74.4% | 4,903 | $90.1K | ||
| 43 | I | Disc Medicine Inc | 0.97% | 75.3% | 1,611 | $89.8K | ||
| 44 | — | Roivant Sciences Ltd. Common Shares | 0.97% | 76.3% | 2,655 | $89.3K | ||
| 45 | I | Immunovant Inc | 0.95% | 77.2% | 3,131 | $87.4K | ||
| 46 | G | Gilead Sciences Inc | 0.94% | 78.2% | 565 | $86.8K | ||
| 47 | V | Vera Therapeutics Inc Class A | 0.91% | 79.1% | 3,143 | $84.0K | ||
| 48 | I | Ionis Pharmaceuticals Inc | 0.90% | 80.0% | 1,935 | $82.6K | ||
| 49 | C | Cogent Biosciences Inc | 0.88% | 80.9% | 2,894 | $81.5K | ||
| 50 | R | Regeneron Pharmaceuticals Inc | 0.83% | 81.7% | 98 | $76.3K | ||
| More holdings · Pro | ||||||||
TDNA ETF All Holdings
TDNA holdings total 87 positions. The top 10 holdings account for 28.7% of the fund, led by Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) at 5.0%, Kymera Therapeutics Inc at 4.2%, Natera Inc at 2.5%.
TDNA portfolio concentration is well-diversified, with the top 10 representing 28.7% of total assets. The largest sector exposure is Health Care at 96.4%.
TDNA sectors provide a detailed breakdown. TDNA overlap shows how holdings compare to other funds in your portfolio.
TDNA ETF Holdings
87 of 87 holdings
- 1
Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
ARGX:ASHealth Care5.03% - 2
Kymera Therapeutics Inc
KYMRHealth Care4.20% - 3
Natera Inc
NTRAHealth Care2.51% - 4
Kodiak Sciences Inc
KODHealth Care2.49% - 5
Vaxcyte Inc
PCVXHealth Care2.46% - 6
Revolution Medicines Inc
RVMDHealth Care2.44% - 7
Moderna Inc
MRNAHealth Care2.43% - 8
Insmed Inc
INSMHealth Care2.42% - 9
United Therapeutics Corp
UTHRHealth Care2.38% - 10
Vertex Pharmaceuticals Inc
VRTXHealth Care2.34% - 11
Alnylam Pharmaceuticals Inc.
ALNYHealth Care1.96% - 12
BridgeBio Pharma Inc
BBIOHealth Care1.94% - 13
Cytokinetics Inc
CYTKHealth Care1.92% - 14
Rhythm Pharmaceuticals Inc
RYTMHealth Care1.80% - 15
Dianthus Therapeutics Inc
DNTHHealth Care1.77% - 16
Spyre Therapeutics Inc
SYREHealth Care1.72% - 17
Praxis Precision Medicines Inc
PRAXHealth Care1.71% - 18
Mirum Pharmaceuticals, Inc.
MIRMHealth Care1.67% - 19
Tango Therapeutics Inc
TNGXHealth Care1.67% - 20
Madrigal Pharmaceuticals Inc
MDGLHealth Care1.66% - 21
CG Oncology Inc
CGONHealth Care1.64% - 22
Arrowhead Pharmaceuticals Inc
ARWRHealth Care1.63% - 23
Alkermes PLC
ALKS:IEHealth Care1.62% - 24
Erasca Inc
ERASHealth Care1.59% - 25
Travere Therapeutics Inc
TVTXHealth Care1.58% - 26
Relay Therapeutics Inc
RLAYHealth Care1.52% - 27
Scholar Rock Holding Corp
SRRKHealth Care1.46% - 28
Twist Bioscience Corp
TWSTHealth Care1.43% - 29
Adarx Pharmaceuticals Inc
Other1.30% - 30
Dyne Therapeutics Inc
DYNHealth Care1.26% - 31
GRAIL Inc
GRALHealth Care1.25% - 32
Biogen Inc
BIIBHealth Care1.16% - 33
Krystal Biotech Inc
KRYSHealth Care1.13% - 34
Beam Therapeutics Inc. Com
BEAMHealth Care1.12% - 35
Nurix Therapeutics Inc
NRIXHealth Care1.10% - 36
Denali Therapeutics Inc
DNLIHealth Care1.05% - 37
Celldex Therapeutics Inc
CLDXHealth Care1.04% - 38
Protagonist Therapeutics Inc
PTGXHealth Care1.01% - 39
IDEAYA Biosciences Inc
IDYAHealth Care0.99% - 40
Amgen Inc.
AMGNHealth Care0.99% - 41
Halozyme Therapeutics Inc
HALOHealth Care0.98% - 42
Viridian Therapeutics Inc
VRDNHealth Care0.98% - 43
Disc Medicine Inc
IRONHealth Care0.97% - 44
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.97% - 45
Immunovant Inc
IMVTHealth Care0.95% - 46
Gilead Sciences Inc
GILDHealth Care0.94% - 47
Vera Therapeutics Inc Class A
VERAHealth Care0.91% - 48
Ionis Pharmaceuticals Inc
IONSHealth Care0.90% - 49
Cogent Biosciences Inc
COGTHealth Care0.88% - 50
Regeneron Pharmaceuticals Inc
REGNHealth Care0.83% - 51
Veracyte Inc
VCYTHealth Care0.83% - 52
Palvella Therapeutics Inc
PVLAHealth Care0.81% - 53
Ascendis Pharma A/S
ASND:COHealth Care0.79% - 54
Summit Therapeutics Inc
SMMTHealth Care0.77% - 55
Incyte Corp
INCYHealth Care0.74% - 56
Xencor Inc
XNCRHealth Care0.74% - 57
Oruka Therapeutics Inc
ORKAHealth Care0.70% - 58
Absci Corp
ABSIHealth Care0.70% - 59
ORIC Pharmaceuticals Inc Class C
ORICHealth Care0.68% - 60
Stoke Therapeutics Inc
STOKHealth Care0.67% - 61
Mineralys Therapeutics Inc
MLYSHealth Care0.66% - 62
Cullinan Therapeutics Inc
CGEMHealth Care0.62% - 63
Monte Rosa Therapeutics Inc
GLUEHealth Care0.62% - 64
Xenon Pharmaceuticals Inc
XENEHealth Care0.62% - 65
Replimune Group Inc
REPLHealth Care0.60% - 66
Tyra Biosciences Inc
TYRAHealth Care0.59% - 67
Celcuity Inc
CELCHealth Care0.57% - 68
First Tracks Biotherapeutics Inc
TRAXUnknown0.54% - 69
Guardant Health, Inc
GHHealth Care0.50% - 70
Compass Pathways Plc Adr
CMPSHealth Care0.44% - 71
Bicara Therapeutics Inc
BCAXHealth Care0.41% - 72
Agios Pharmaceuticals Inc
AGIOHealth Care0.38% - 73
10x Genomics Inc Class A
TXGHealth Care0.37% - 74
Arcus Biosciences Inc
RCUSHealth Care0.36% - 75
Definium Therapeutics Inc
DFTX:CAUnknown0.34% - 76
Enliven Therapeutics Inc
ELVNHealth Care0.34% - 77
Corvus Pharmaceuticals Inc
CRVSHealth Care0.33% - 78
Avalo Therapeutics Inc
AVTXHealth Care0.32% - 79
Abivax Sa-Adr
ABVXUnknown0.32% - 80
LB Pharmaceuticals Inc
LBRXUnknown0.30% - 81
Trevi Therapeutics Inc
TRVIHealth Care0.30% - 82
Alto Neuroscience Inc Class C
ANROHealth Care0.27% - 83
Eikon Therapeutics Inc
EIKNUnknown0.26% - 84
Generate Biomedicines Inc
GENBUnknown0.25% - 85
Eliem Therapeutics Inc
ELYMHealth Care0.24% - 86
Avalyn Pharma Inc
AVLNUnknown0.22% - 87
Adarx Pharmaceuticals Inc
Other0.18%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) | ARGX:AS | 5.030% | ||
| 2 | Kymera Therapeutics Inc | KYMR | 4.200% | ||
| 3 | Natera Inc | NTRA | 2.510% | ||
| 4 | Kodiak Sciences Inc | KOD | 2.490% | ||
| 5 | Vaxcyte Inc | PCVX | 2.460% | ||
| 6 | Revolution Medicines Inc | RVMD | 2.440% | ||
| 7 | Moderna Inc | MRNA | 2.430% | ||
| 8 | Insmed Inc | INSM | 2.420% | ||
| 9 | United Therapeutics Corp | UTHR | 2.380% | ||
| 10 | Vertex Pharmaceuticals Inc | VRTX | 2.340% | ||
| 11 | Alnylam Pharmaceuticals Inc. | ALNY | 1.960% | ||
| 12 | BridgeBio Pharma Inc | BBIO | 1.940% | ||
| 13 | Cytokinetics Inc | CYTK | 1.920% | ||
| 14 | Rhythm Pharmaceuticals Inc | RYTM | 1.800% | ||
| 15 | Dianthus Therapeutics Inc | DNTH | 1.770% | ||
| 16 | Spyre Therapeutics Inc | SYRE | 1.720% | ||
| 17 | Praxis Precision Medicines Inc | PRAX | 1.710% | ||
| 18 | Mirum Pharmaceuticals, Inc. | MIRM | 1.670% | ||
| 19 | Tango Therapeutics Inc | TNGX | 1.670% | ||
| 20 | Madrigal Pharmaceuticals Inc | MDGL | 1.660% | ||
| 21 | CG Oncology Inc | CGON | 1.640% | ||
| 22 | Arrowhead Pharmaceuticals Inc | ARWR | 1.630% | ||
| 23 | Alkermes PLC | ALKS:IE | 1.620% | ||
| 24 | Erasca Inc | ERAS | 1.590% | ||
| 25 | Travere Therapeutics Inc | TVTX | 1.580% | ||
| 26 | Relay Therapeutics Inc | RLAY | 1.520% | ||
| 27 | Scholar Rock Holding Corp | SRRK | 1.460% | ||
| 28 | Twist Bioscience Corp | TWST | 1.430% | ||
| 29 | Adarx Pharmaceuticals Inc | - | 1.300% | ||
| 30 | Dyne Therapeutics Inc | DYN | 1.260% | ||
| 31 | GRAIL Inc | GRAL | 1.250% | ||
| 32 | Biogen Inc | BIIB | 1.160% | ||
| 33 | Krystal Biotech Inc | KRYS | 1.130% | ||
| 34 | Beam Therapeutics Inc. Com | BEAM | 1.120% | ||
| 35 | Nurix Therapeutics Inc | NRIX | 1.100% | ||
| 36 | Denali Therapeutics Inc | DNLI | 1.050% | ||
| 37 | Celldex Therapeutics Inc | CLDX | 1.040% | ||
| 38 | Protagonist Therapeutics Inc | PTGX | 1.010% | ||
| 39 | IDEAYA Biosciences Inc | IDYA | 0.990% | ||
| 40 | Amgen Inc. | AMGN | 0.990% | ||
| 41 | Halozyme Therapeutics Inc | HALO | 0.980% | ||
| 42 | Viridian Therapeutics Inc | VRDN | 0.980% | ||
| 43 | Disc Medicine Inc | IRON | 0.970% | ||
| 44 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.970% | ||
| 45 | Immunovant Inc | IMVT | 0.950% | ||
| 46 | Gilead Sciences Inc | GILD | 0.940% | ||
| 47 | Vera Therapeutics Inc Class A | VERA | 0.910% | ||
| 48 | Ionis Pharmaceuticals Inc | IONS | 0.900% | ||
| 49 | Cogent Biosciences Inc | COGT | 0.880% | ||
| 50 | Regeneron Pharmaceuticals Inc | REGN | 0.830% | ||
| 51 | Veracyte Inc | VCYT | 0.830% | ||
| 52 | Palvella Therapeutics Inc | PVLA | 0.810% | ||
| 53 | Ascendis Pharma A/S | ASND:CO | 0.790% | ||
| 54 | Summit Therapeutics Inc | SMMT | 0.770% | ||
| 55 | Incyte Corp | INCY | 0.740% | ||
| 56 | Xencor Inc | XNCR | 0.740% | ||
| 57 | Oruka Therapeutics Inc | ORKA | 0.700% | ||
| 58 | Absci Corp | ABSI | 0.700% | ||
| 59 | ORIC Pharmaceuticals Inc Class C | ORIC | 0.680% | ||
| 60 | Stoke Therapeutics Inc | STOK | 0.670% | ||
| 61 | Mineralys Therapeutics Inc | MLYS | 0.660% | ||
| 62 | Cullinan Therapeutics Inc | CGEM | 0.620% | ||
| 63 | Monte Rosa Therapeutics Inc | GLUE | 0.620% | ||
| 64 | Xenon Pharmaceuticals Inc | XENE | 0.620% | ||
| 65 | Replimune Group Inc | REPL | 0.600% | ||
| 66 | Tyra Biosciences Inc | TYRA | 0.590% | ||
| 67 | Celcuity Inc | CELC | 0.570% | ||
| 68 | First Tracks Biotherapeutics Inc | TRAX | 0.540% | ||
| 69 | Guardant Health, Inc | GH | 0.500% | ||
| 70 | Compass Pathways Plc Adr | CMPS | 0.440% | ||
| 71 | Bicara Therapeutics Inc | BCAX | 0.410% | ||
| 72 | Agios Pharmaceuticals Inc | AGIO | 0.380% | ||
| 73 | 10x Genomics Inc Class A | TXG | 0.370% | ||
| 74 | Arcus Biosciences Inc | RCUS | 0.360% | ||
| 75 | Definium Therapeutics Inc | DFTX:CA | 0.340% | ||
| 76 | Enliven Therapeutics Inc | ELVN | 0.340% | ||
| 77 | Corvus Pharmaceuticals Inc | CRVS | 0.330% | ||
| 78 | Avalo Therapeutics Inc | AVTX | 0.320% | ||
| 79 | Abivax Sa-Adr | ABVX | 0.320% | ||
| 80 | LB Pharmaceuticals Inc | LBRX | 0.300% | ||
| 81 | Trevi Therapeutics Inc | TRVI | 0.300% | ||
| 82 | Alto Neuroscience Inc Class C | ANRO | 0.270% | ||
| 83 | Eikon Therapeutics Inc | EIKN | 0.260% | ||
| 84 | Generate Biomedicines Inc | GENB | 0.250% | ||
| 85 | Eliem Therapeutics Inc | ELYM | 0.240% | ||
| 86 | Avalyn Pharma Inc | AVLN | 0.220% | ||
| 87 | Adarx Pharmaceuticals Inc | - | 0.180% |













































